Cargando…

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort

BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonilla, Carolina, Lewis, Sarah J., Martin, Richard M., Donovan, Jenny L., Hamdy, Freddie C., Neal, David E., Eeles, Rosalind, Easton, Doug, Kote-Jarai, Zsofia, Al Olama, Ali Amin, Benlloch, Sara, Muir, Kenneth, Giles, Graham G., Wiklund, Fredrik, Gronberg, Henrik, Haiman, Christopher A., Schleutker, Johanna, Nordestgaard, Børge G., Travis, Ruth C., Pashayan, Nora, Khaw, Kay-Tee, Stanford, Janet L., Blot, William J., Thibodeau, Stephen, Maier, Christiane, Kibel, Adam S., Cybulski, Cezary, Cannon-Albright, Lisa, Brenner, Hermann, Park, Jong, Kaneva, Radka, Batra, Jyotsna, Teixeira, Manuel R., Pandha, Hardev, Lathrop, Mark, Davey Smith, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820939/
https://www.ncbi.nlm.nih.gov/pubmed/27044414
http://dx.doi.org/10.1186/s12916-016-0602-x
_version_ 1782425500679929856
author Bonilla, Carolina
Lewis, Sarah J.
Martin, Richard M.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Eeles, Rosalind
Easton, Doug
Kote-Jarai, Zsofia
Al Olama, Ali Amin
Benlloch, Sara
Muir, Kenneth
Giles, Graham G.
Wiklund, Fredrik
Gronberg, Henrik
Haiman, Christopher A.
Schleutker, Johanna
Nordestgaard, Børge G.
Travis, Ruth C.
Pashayan, Nora
Khaw, Kay-Tee
Stanford, Janet L.
Blot, William J.
Thibodeau, Stephen
Maier, Christiane
Kibel, Adam S.
Cybulski, Cezary
Cannon-Albright, Lisa
Brenner, Hermann
Park, Jong
Kaneva, Radka
Batra, Jyotsna
Teixeira, Manuel R.
Pandha, Hardev
Lathrop, Mark
Davey Smith, George
author_facet Bonilla, Carolina
Lewis, Sarah J.
Martin, Richard M.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Eeles, Rosalind
Easton, Doug
Kote-Jarai, Zsofia
Al Olama, Ali Amin
Benlloch, Sara
Muir, Kenneth
Giles, Graham G.
Wiklund, Fredrik
Gronberg, Henrik
Haiman, Christopher A.
Schleutker, Johanna
Nordestgaard, Børge G.
Travis, Ruth C.
Pashayan, Nora
Khaw, Kay-Tee
Stanford, Janet L.
Blot, William J.
Thibodeau, Stephen
Maier, Christiane
Kibel, Adam S.
Cybulski, Cezary
Cannon-Albright, Lisa
Brenner, Hermann
Park, Jong
Kaneva, Radka
Batra, Jyotsna
Teixeira, Manuel R.
Pandha, Hardev
Lathrop, Mark
Davey Smith, George
author_sort Bonilla, Carolina
collection PubMed
description BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach. METHODS: We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample. RESULTS: In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64–0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43–91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91–1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90–0.98), but not with disease grade. CONCLUSIONS: Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0602-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4820939
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48209392016-04-06 Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort Bonilla, Carolina Lewis, Sarah J. Martin, Richard M. Donovan, Jenny L. Hamdy, Freddie C. Neal, David E. Eeles, Rosalind Easton, Doug Kote-Jarai, Zsofia Al Olama, Ali Amin Benlloch, Sara Muir, Kenneth Giles, Graham G. Wiklund, Fredrik Gronberg, Henrik Haiman, Christopher A. Schleutker, Johanna Nordestgaard, Børge G. Travis, Ruth C. Pashayan, Nora Khaw, Kay-Tee Stanford, Janet L. Blot, William J. Thibodeau, Stephen Maier, Christiane Kibel, Adam S. Cybulski, Cezary Cannon-Albright, Lisa Brenner, Hermann Park, Jong Kaneva, Radka Batra, Jyotsna Teixeira, Manuel R. Pandha, Hardev Lathrop, Mark Davey Smith, George BMC Med Research Article BACKGROUND: Epidemiological studies have observed a positive association between an earlier age at sexual development and prostate cancer, but markers of sexual maturation in boys are imprecise and observational estimates are likely to suffer from a degree of uncontrolled confounding. To obtain causal estimates, we examined the role of pubertal development in prostate cancer using genetic polymorphisms associated with Tanner stage in adolescent boys in a Mendelian randomization (MR) approach. METHODS: We derived a weighted genetic risk score for pubertal development, combining 13 SNPs associated with male Tanner stage. A higher score indicated a later puberty onset. We examined the association of this score with prostate cancer risk, stage and grade in the UK-based ProtecT case-control study (n = 2,927), and used the PRACTICAL consortium (n = 43,737) as a replication sample. RESULTS: In ProtecT, the puberty genetic score was inversely associated with prostate cancer grade (odds ratio (OR) of high- vs. low-grade cancer, per tertile of the score: 0.76; 95 % CI, 0.64–0.89). In an instrumental variable estimation of the causal OR, later physical development in adolescence (equivalent to a difference of one Tanner stage between pubertal boys of the same age) was associated with a 77 % (95 % CI, 43–91 %) reduced odds of high Gleason prostate cancer. In PRACTICAL, the puberty genetic score was associated with prostate cancer stage (OR of advanced vs. localized cancer, per tertile: 0.95; 95 % CI, 0.91–1.00) and prostate cancer-specific mortality (hazard ratio amongst cases, per tertile: 0.94; 95 % CI, 0.90–0.98), but not with disease grade. CONCLUSIONS: Older age at sexual maturation is causally linked to a reduced risk of later prostate cancer, especially aggressive disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-016-0602-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-04 /pmc/articles/PMC4820939/ /pubmed/27044414 http://dx.doi.org/10.1186/s12916-016-0602-x Text en © Bonilla et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bonilla, Carolina
Lewis, Sarah J.
Martin, Richard M.
Donovan, Jenny L.
Hamdy, Freddie C.
Neal, David E.
Eeles, Rosalind
Easton, Doug
Kote-Jarai, Zsofia
Al Olama, Ali Amin
Benlloch, Sara
Muir, Kenneth
Giles, Graham G.
Wiklund, Fredrik
Gronberg, Henrik
Haiman, Christopher A.
Schleutker, Johanna
Nordestgaard, Børge G.
Travis, Ruth C.
Pashayan, Nora
Khaw, Kay-Tee
Stanford, Janet L.
Blot, William J.
Thibodeau, Stephen
Maier, Christiane
Kibel, Adam S.
Cybulski, Cezary
Cannon-Albright, Lisa
Brenner, Hermann
Park, Jong
Kaneva, Radka
Batra, Jyotsna
Teixeira, Manuel R.
Pandha, Hardev
Lathrop, Mark
Davey Smith, George
Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title_full Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title_fullStr Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title_full_unstemmed Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title_short Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort
title_sort pubertal development and prostate cancer risk: mendelian randomization study in a population-based cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820939/
https://www.ncbi.nlm.nih.gov/pubmed/27044414
http://dx.doi.org/10.1186/s12916-016-0602-x
work_keys_str_mv AT bonillacarolina pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT lewissarahj pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT martinrichardm pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT donovanjennyl pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT hamdyfreddiec pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT nealdavide pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT eelesrosalind pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT eastondoug pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT kotejaraizsofia pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT alolamaaliamin pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT benllochsara pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT muirkenneth pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT gilesgrahamg pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT wiklundfredrik pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT gronberghenrik pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT haimanchristophera pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT schleutkerjohanna pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT nordestgaardbørgeg pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT travisruthc pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT pashayannora pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT khawkaytee pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT stanfordjanetl pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT blotwilliamj pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT thibodeaustephen pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT maierchristiane pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT kibeladams pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT cybulskicezary pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT cannonalbrightlisa pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT brennerhermann pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT parkjong pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT kanevaradka pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT batrajyotsna pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT teixeiramanuelr pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT pandhahardev pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT lathropmark pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT daveysmithgeorge pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort
AT pubertaldevelopmentandprostatecancerriskmendelianrandomizationstudyinapopulationbasedcohort